WHY IT MATTERS: Pregnant patients who have used cannabis, even early in pregnancy, may want to discuss this emerging research with their obstetric and psychiatric care teams when considering their child’s long-term neurodevelopmental monitoring. CLINICAL OVERVIEW: Emerging research suggests that prenatal cannabis exposure may produce measurable epigenetic and gene expression changes in placental tissue, particularly in pathways associated with neurodevelopmental risk including schizophrenia. The placenta, long underappreciated as a window into fetal programming, appears to reflect cannabis-related disruptions that could correlate with altered brain development trajectories in offspring.
Cannabis and Pregnancy: 5 Hidden Truths Doctors Ignore
Cannabis and pregnancy is not a black-and-white issue—but you wouldn’t know that from most media headlines. In this thought-provoking piece, Dr. Caplan breaks down the uncomfortable truths about risk, suffering, and why patients deserve personalized, harm-reduction-focused care today. The future of pregnancy care demands we stop sweeping these conversations under the rug—and start facing them with honesty and compassion.